VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer. [electronic resource]
Producer: 20131223Description: 151-61 p. digitalISSN:- 1538-8514
- Animals
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Colorectal Neoplasms -- drug therapy
- Disease Models, Animal
- Female
- Gastrointestinal Neoplasms -- drug therapy
- Humans
- Male
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Mice, SCID
- Morpholines -- adverse effects
- Neoplasms -- drug therapy
- PTEN Phosphohydrolase -- deficiency
- Phosphoinositide-3 Kinase Inhibitors
- Prostatic Neoplasms -- drug therapy
- Protein Kinase Inhibitors -- adverse effects
- Purines -- adverse effects
- Signal Transduction
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.